Guiyang Xintian Pharmaceutical Co.,Ltd. (SZSE: 002873)
Health Care · Pharmaceuticals · CN
CN¥8.44
+0.48% today · -36.6% 1Y
Guiyang Xintian Pharmaceutical Co.,Ltd. (SZSE: 002873) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $295.42M and employs 1,388 people.
Over the last twelve months the share price has lost 36.6%, trading between 7.04 and 14.02.
Tweenvest scores Guiyang Xintian Pharmaceutical Co.,Ltd. across four factors: quality 69/100, value 35/100, growth 0/100, dividend 20/100. Its strongest factor is quality.
002873 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $295.42M
- Revenue (TTM)
- $106.59M
- P/E
- 236.26
- EPS
- 0.04
- Dividend yield
- 0.36%
- Beta (5Y)
- -0.01
- 52-week high
- CN¥14.02
- 52-week low
- CN¥7.04
- Avg volume (3M)
- —
- Shares outstanding
- 235.30M
- Employees
- 1,388
- Next earnings
- —
About Guiyang Xintian Pharmaceutical Co.,Ltd.
Guiyang Xintian Pharmaceutical Co.,Ltd. is a Chinese company dedicated to the research, development, production, and commercialization of traditional Chinese medicines (TCMs) for a wide range of ailments. Its product offerings include various pharmaceutical formulations such as hard capsules, gels, mixtures, granules, and tablets. These medicines are specifically designed to treat diverse medical conditions, including antitumor applications, gynecological issues, urinary tract problems, breast and thyroid disorders, blood-related illnesses, heat-related syndromes, oral health complaints, common colds, and cardiovascular diseases. The company was founded in 1995 and is headquartered in Guiyang, China.
- ISIN
- CNE100002QB5
- Founded
- 1995
- Listed since
- May 19, 2017
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.22 | -0.96% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.